Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FN0T4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,163
Award facts
- Contract value 100% obligated
- $17,162.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,162.79 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. This firm fixed-price, competitively awarded contract was executed on January 21, 2026, with an ultimate completion date of January 22, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies a diverse portfolio of medications and medical supplies to federal agencies, particularly the Department of Defense and Veterans Affairs systems. The company was selected through full and open competition with no set-aside designation. Orencia (abatacept) is a biologic immunosuppressant medication commonly used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflecting the company's ongoing role in fulfilling critical pharmaceutical needs for military and veteran healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FN0T4?
SPE2DR26FN0T4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FN0T4 worth?
The government has obligated $17,163 on SPE2DR26FN0T4.
Is contract SPE2DR26FN0T4 an order under another contract?
Yes. SPE2DR26FN0T4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0T4 competed?
The extent of competition for SPE2DR26FN0T4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award